These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 3707648

  • 1. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
    De Vita C, Triulzi E, Devizzi S, Colombo G, Palvarini M, Pocchiari F, Pataccini R.
    Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A, Mussini A, Bramucci E.
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L, Ibba GV, Castellaccio M, Dore L.
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L, Metra M, Nodari S, Visioli O.
    J Cardiovasc Pharmacol; 1989 Feb; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [Abstract] [Full Text] [Related]

  • 5. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
    Humar F, Morgera T, Maras P, Camerini F.
    Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
    [Abstract] [Full Text] [Related]

  • 6. Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure.
    Musacci GF, Ansani L, Toselli T, Aggio S, Baracca E, Longhini C.
    Arzneimittelforschung; 1986 Feb; 36(2A):380-2. PubMed ID: 3707654
    [Abstract] [Full Text] [Related]

  • 7. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
    Kopia GA, Ohlstein EH, Ruffolo RR.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
    [Abstract] [Full Text] [Related]

  • 8. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in dogs.
    Pocchiari F, Pataccini R, Castelnovo P, Longo A, Paro M, Casagrande C.
    Arzneimittelforschung; 1986 Feb; 36(2A):341-4. PubMed ID: 3707646
    [Abstract] [Full Text] [Related]

  • 9. Ibopamine kinetics after single and multiple dosing in patients with congestive heart failure.
    Azzollini F, De Caro L, Longo A, Pelosi G, Rolandi E, Ventresca GP, Lodola E.
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):544-51. PubMed ID: 3243658
    [Abstract] [Full Text] [Related]

  • 10. Ibopamine kinetics after a single oral dose in patients with congestive heart failure.
    Azzollini F, Cattò G, Iacuitti G, Pelosi G, Picca M, Pocchiari F, Pataccini R, Castelnovo P, Longo A, Ventresca GP.
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):105-12. PubMed ID: 3410586
    [Abstract] [Full Text] [Related]

  • 11. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
    Di Mario C, Compostella L, Iavernaro A, Libardoni M, Ghirardi P, Cucchini F.
    Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
    [Abstract] [Full Text] [Related]

  • 12. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in rats.
    Pocchiari F, Pataccini R, Castelnovo P, Longo A, Casagrande C.
    Arzneimittelforschung; 1986 Feb; 36(2A):334-40. PubMed ID: 3707645
    [Abstract] [Full Text] [Related]

  • 13. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
    Avanzini Z, Bellogini GC, Brusoni B, Ciampani N, Dei Cas L, Gazzola U, Maggi GC, Mangiavacchi M, Metra M, Pinca L.
    Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
    [Abstract] [Full Text] [Related]

  • 14. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
    Merlo L, Ghirardi P, Brusoni B, Mussini E, Marchetti G.
    Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
    [Abstract] [Full Text] [Related]

  • 15. Ibopamine kinetics after a single oral dose in healthy volunteers.
    Lodola E, Borgia M, Longo A, Pocchiari F, Pataccini R, Sher D.
    Arzneimittelforschung; 1986 Feb; 36(2A):345-8. PubMed ID: 3707647
    [Abstract] [Full Text] [Related]

  • 16. Effects of ibopamine on acute cardiac failure following experimental coronary occlusion in dogs.
    Marchetti G, Merlo L.
    Arzneimittelforschung; 1986 Feb; 36(2A):331-3. PubMed ID: 3707644
    [Abstract] [Full Text] [Related]

  • 17. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T, Morimoto Y, Kakuta Y, Konishi T, Kodera T, Kanamaru M, Takezawa H.
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [Abstract] [Full Text] [Related]

  • 18. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA, Nara AR, Pospisil RA, Stoddard GJ, Schleman M.
    Pharmacotherapy; 1993 Dec; 13(3):218-23. PubMed ID: 8100627
    [Abstract] [Full Text] [Related]

  • 19. Positive inotropic effects of ibopamine in patients with congestive heart failure. A multicenter investigation.
    Caponnetto S, Allegro A, Bellotti G, Cataldi A, Salvemini M, Portioli I, Prati PL, Gambelli G, Boccanelli A, Zacharo E.
    Arzneimittelforschung; 1986 Feb; 36(2A):386-90. PubMed ID: 3518725
    [Abstract] [Full Text] [Related]

  • 20. Clinical pharmacokinetics of ibopamine on different diseases and conditions.
    Ventresca GP, Lodola E.
    Arzneimittelforschung; 1988 Aug; 38(8):1175-80. PubMed ID: 2904270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.